Article

Intrableb pigmentation a good sign after filtration surgery

Intrableb pigmentation may be a positive sign in bleb filtration surgery, said Boonsong Wanichwecharungruang, MD, from Rajavithi Hospital, Bangkok, Thailand.

Intrableb pigmentation may be a positive sign in bleb filtration surgery, said Boonsong Wanichwecharungruang, MD, fromRajavithi Hospital, Bangkok, Thailand.

Dr. Wanichwecharungruang divided the pigmentation based on the degree from mild to very dark, almost black.

When he and his colleagues compared the results from 44 cases with intrableb pigmentation versus 40 controls withoutpigmentation, they found that the complete success rate was better in the group with intrableb pigmentation after a follow-upof about 2 years.

"Intrableb pigmentation was associated with thin and cystic blebs," he said. The overall success, the mean IOP, and the meanreduction in the number of postoperative glaucoma medications were not significant but were better in the group withintrableb pigmentation.

Intrableb pigmentation, which originates from uveal melanocytes, is associated with a thin-walled bleb, which in turn allowsbetter flow of aqueous humor and better detection of pigmentation, he explained.

"Intrableb pigmentation presents as a tracer element of aqueous flow from the anterior chamber to the filtering bleb," Dr.Wanichwecharungruang said. "The pigmentation appears to be a favorable sign of filtering surgery, but a much larger samplesize and longer follow-up are needed."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.